Cell-cycle-gated feedback control mediates desensitization to interferon stimulation
暂无分享,去创建一个
Wei Wang | N. Hao | M. Daugherty | Dong-er Zhang | K. Arimoto | Anusorn Mudla | Yanfei Jiang | Bingxian Xu | Adarsh Rajesh | Andy P Ryan
[1] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[2] Y. Yazdanpanah,et al. Type 1 interferons as a potential treatment against COVID-19 , 2020, Antiviral Research.
[3] Chengzhe Tian,et al. Temporal integration of mitogen history in mother cells controls proliferation of daughter cells , 2020, Science.
[4] Vineet D. Menachery,et al. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. , 2020, bioRxiv.
[5] Vineet D. Menachery,et al. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV , 2020, Journal of Virology.
[6] A. Hoffmann,et al. Gene Regulatory Strategies that Decode the Duration of NFκB Dynamics Contribute to LPS- versus TNF-Specific Gene Expression. , 2020, Cell systems.
[7] A. Sher,et al. Visualizing the Selectivity and Dynamics of Interferon Signaling In Vivo. , 2019, Cell reports.
[8] Abhyudai Singh,et al. p53 pulse modulation differentially regulates target gene promoters to regulate cell fate decisions , 2019, Molecular systems biology.
[9] Steven J. Altschuler,et al. Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy , 2019, Cell.
[10] Abdullahi Umar Ibrahim,et al. Genome Engineering Using the CRISPR Cas9 System , 2019 .
[11] Markus W. Covert,et al. Techniques for Studying Decoding of Single Cell Dynamics , 2019, Front. Immunol..
[12] V. Dötsch,et al. Cell cycle arrest in mitosis promotes interferon-induced necroptosis , 2019, Cell Death & Differentiation.
[13] K. Sakaguchi,et al. Interferon stimulation creates chromatin marks and establishes transcriptional memory , 2018, Proceedings of the National Academy of Sciences.
[14] E. Marder,et al. Cellular function given parametric variation in the Hodgkin and Huxley model of excitability , 2018, Proceedings of the National Academy of Sciences.
[15] Jia-Yun Chen,et al. Fluctuations in p53 Signaling Allow Escape from Cell-Cycle Arrest. , 2019, Molecular cell.
[16] Haidong Gao,et al. USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway. , 2018, International journal of oncology.
[17] S. Yao,et al. The molecular basis of JAK/STAT inhibition by SOCS1 , 2018, Nature Communications.
[18] Yuh Shiwa,et al. iMETHYL: an integrative database of human DNA methylation, gene expression, and genomic variation , 2018, Human Genome Variation.
[19] C. Scagnolari,et al. Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome , 2018, Cytokine & Growth Factor Reviews.
[20] Kevin Thurley,et al. Modeling Cell-to-Cell Communication Networks Using Response-Time Distributions , 2018, Cell systems.
[21] Viktória Hudacsek,et al. [Genome engineering using the CRISPR-Cas9 system and applications in cancer research]. , 2018, Magyar onkologia.
[22] M. Kimmel,et al. Cell fate in antiviral response arises in the crosstalk of IRF, NF-κB and JAK/STAT pathways , 2018, Nature Communications.
[23] G. Stark,et al. Interferon-beta represses cancer stem cell properties in triple-negative breast cancer , 2017, Proceedings of the National Academy of Sciences.
[24] N. Hao,et al. Mitogen-activated protein kinase (MAPK) dynamics determine cell fate in the yeast mating response , 2017, The Journal of Biological Chemistry.
[25] Jeff Hasty,et al. Multigenerational silencing dynamics control cell aging , 2017, Proceedings of the National Academy of Sciences.
[26] T. Meyer,et al. Competing memories of mitogen and p53 signalling control cell-cycle entry , 2017, Nature.
[27] B. Strauss,et al. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy , 2017, Oncotarget.
[28] B. Strauss,et al. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy , 2017, Oncotarget.
[29] L. Tsimring,et al. Coupled feedback loops control the stimulus-dependent dynamics of the yeast transcription factor Msn2 , 2017, The Journal of Biological Chemistry.
[30] G. Schreiber. The molecular basis for differential type I interferon signaling , 2017, The Journal of Biological Chemistry.
[31] Clifford A. Meyer,et al. Transcriptional landscape of the human cell cycle , 2017, Proceedings of the National Academy of Sciences.
[32] Ming Yan,et al. STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling , 2017, Nature Structural &Molecular Biology.
[33] T. Langan,et al. Synchronization of Mammalian Cell Cultures by Serum Deprivation. , 2017, Methods in molecular biology.
[34] Michael Z. Lin,et al. Fluorescent indicators for simultaneous reporting of all four cell cycle phases , 2016, Nature Methods.
[35] Omar P. Tabbaa,et al. Dynamic control of gene regulatory logic by seemingly redundant transcription factors , 2016, eLife.
[36] H. Herzel,et al. Excitability in the p53 network mediates robust signaling with tunable activation thresholds in single cells , 2016, Scientific Reports.
[37] M. Crow. Autoimmunity: Interferon α or β: which is the culprit in autoimmune disease? , 2016, Nature Reviews Rheumatology.
[38] H. Decaluwe,et al. Cytokines and persistent viral infections. , 2016, Cytokine.
[39] G. Lahav,et al. Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing , 2016, Cell.
[40] Anatoly Kiyatkin,et al. The Dark Side of Cell Signaling: Positive Roles for Negative Regulators , 2016, Cell.
[41] W. Lim,et al. Oscillatory stress stimulation uncovers an Achilles’ heel of the yeast MAPK signaling network , 2015, Science.
[42] M. Ocker,et al. Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study. , 2015, Oncology reports.
[43] E. O’Shea,et al. cis Determinants of Promoter Threshold and Activation Timescale. , 2015, Cell reports.
[44] Sanjay Tyagi,et al. Single-cell analysis shows that paracrine signaling by first responder cells shapes the interferon-β response to viral infection , 2015, Science Signaling.
[45] A. Sher,et al. Type I interferons in infectious disease , 2015, Nature Reviews Immunology.
[46] P. Arimondo,et al. Combined analysis of DNA methylation and cell cycle in cancer cells , 2015, Epigenetics.
[47] V. Pascual,et al. IFN Priming Is Necessary but Not Sufficient To Turn on a Migratory Dendritic Cell Program in Lupus Monocytes , 2014, The Journal of Immunology.
[48] W. Średniawa,et al. Dynamic JUNQ inclusion bodies are asymmetrically inherited in mammalian cell lines through the asymmetric partitioning of vimentin , 2014, Proceedings of the National Academy of Sciences.
[49] M. De la Fuente,et al. Chronic Inflammation and Cytokines in the Tumor Microenvironment , 2014, Journal of immunology research.
[50] C. Rice,et al. Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.
[51] R. Randall,et al. Activation of the Interferon Induction Cascade by Influenza A Viruses Requires Viral RNA Synthesis and Nuclear Export , 2014, Journal of Virology.
[52] Jared E. Toettcher,et al. Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module , 2013, Cell.
[53] Anders S Hansen,et al. Promoter decoding of transcription factor dynamics involves a trade-off between noise and control of gene expression , 2013 .
[54] David A. Scott,et al. Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.
[55] Javier A. Carrero. Confounding roles for type I interferons during bacterial and viral pathogenesis , 2013, International immunology.
[56] Sabrina L. Spencer,et al. The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit , 2013, Cell.
[57] C. Rice,et al. IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage , 2013, The EMBO journal.
[58] Wun-Jae Kim,et al. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[59] G. Lahav,et al. Encoding and Decoding Cellular Information through Signaling Dynamics , 2013, Cell.
[60] Jeremy Gunawardena,et al. Tunable Signal Processing Through Modular Control of Transcription Factor Translocation , 2013, Science.
[61] K. Shuai,et al. UBP 43 is a novel regulator of interferon signaling independent of its ISG 15 isopeptidase activity , 2013 .
[62] K. Matsuura,et al. Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene , 2012, Gut.
[63] L. Tsimring,et al. Vacuum-assisted cell loading enables shear-free mammalian microfluidic culture. , 2012, Lab on a chip.
[64] J. Kirkwood,et al. IFN-α in the Treatment of Melanoma , 2012, The Journal of Immunology.
[65] Jeremy E. Purvis,et al. p53 Dynamics Control Cell Fate , 2012, Science.
[66] Thomas Höfer,et al. Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response , 2012, Molecular systems biology.
[67] Erin K O'Shea,et al. Signal-dependent dynamics of transcription factor translocation controls gene expression , 2011, Nature Structural &Molecular Biology.
[68] D. Choubey,et al. Interferons in autoimmune and inflammatory diseases: regulation and roles. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[69] C. Rice,et al. Interferon-stimulated genes and their antiviral effector functions , 2011, Current Opinion in Virology.
[70] S. Pellegrini,et al. USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response , 2011, PloS one.
[71] Galit Lahav,et al. Stimulus-dependent dynamics of p53 in single cells , 2011, Molecular systems biology.
[72] A. Yoshimura,et al. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[73] D. Tough,et al. Interferon‐β and interferon‐λ signaling is not affected by interferon‐induced refractoriness to interferon‐α in vivo , 2011, Hepatology.
[74] M. Heim,et al. 44 INTERFERON-β AND -λ SIGNALING IS NOT AFFECTED BY INTERFERON-INDUCED REFRACTORINESS TO INTERFERON-α IN VIVO , 2011 .
[75] T. Langan,et al. Synchronization of mammalian cell cultures by serum deprivation. , 2011, Methods in molecular biology.
[76] Alexander Hoffmann,et al. Understanding the temporal codes of intra-cellular signals. , 2010, Current opinion in genetics & development.
[77] Timothy K Lee,et al. Single-cell NF-κB dynamics reveal digital activation and analogue information processing , 2010, Nature.
[78] Alan S. Perelson,et al. Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus , 2010, Journal of Virology.
[79] L. Tsimring,et al. A synchronized quorum of genetic clocks , 2009, Nature.
[80] Zhenghong Yuan,et al. Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. , 2009, The Journal of general virology.
[81] K. Zoon,et al. IRF9 is a Key Factor for Eliciting the Antiproliferative Activity of IFN-α , 2009, Journal of immunotherapy.
[82] Ming Yan,et al. Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43 , 2009, Molecular and Cellular Biology.
[83] D. S. Broomhead,et al. Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription , 2009, Science.
[84] Dong-er Zhang,et al. The Level of Hepatitis B Virus Replication Is Not Affected by Protein ISG15 Modification but Is Reduced by Inhibition of UBP43 (USP18) Expression1 , 2008, The Journal of Immunology.
[85] S. Sealfon,et al. Interferon-β Pretreatment of Conventional and Plasmacytoid Human Dendritic Cells Enhances Their Activation by Influenza Virus , 2008, PLoS pathogens.
[86] K. Keyomarsi,et al. Synchronization of the cell cycle using Lovastatin , 2008, Cell cycle.
[87] Megan N. McClean,et al. Signal processing by the HOG MAP kinase pathway , 2008, Proceedings of the National Academy of Sciences.
[88] Jerome T. Mettetal,et al. The Frequency Dependence of Osmo-Adaptation in Saccharomyces cerevisiae , 2008, Science.
[89] Ali Danesh,et al. Human immunopathogenesis of severe acute respiratory syndrome (SARS) , 2007, Virus Research.
[90] Ming Yan,et al. Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. , 2007, Biochemical and biophysical research communications.
[91] M. Fraga,et al. Variations in DNA Methylation Patterns During the Cell Cycle of HeLa Cells , 2007, Epigenetics.
[92] K. Shuai,et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity , 2006, The EMBO journal.
[93] Gürol M. Süel,et al. An excitable gene regulatory circuit induces transient cellular differentiation , 2006, Nature.
[94] R. Momparler. Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine). , 2005, Seminars in oncology.
[95] D. Baltimore,et al. Achieving Stability of Lipopolysaccharide-Induced NF-κB Activation , 2005, Science.
[96] G. Cheng,et al. The host type I interferon response to viral and bacterial infections , 2005, Cell Research.
[97] L. Platanias. Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.
[98] T. Whiteside,et al. Alpha-interferon , 1989, Digestive Diseases and Sciences.
[99] gangChen,et al. The host type I interferon response to viral and bacterial infections , 2005 .
[100] David Baltimore,et al. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. , 2005, Science.
[101] Ming Yan,et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection , 2004, Nature Medicine.
[102] James R. Johnson,et al. Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.
[103] D B Kell,et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. , 2004, Science.
[104] S. Mangan,et al. The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks. , 2003, Journal of molecular biology.
[105] D. Lavelle,et al. Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway. , 2003, Leukemia research.
[106] Ming Yan,et al. Protein ISGylation modulates the JAK-STAT signaling pathway. , 2003, Genes & development.
[107] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[108] Takeshi Norimatsu,et al. Encoding and Decoding , 2016 .
[109] J. Christman,et al. 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy , 2002, Oncogene.
[110] S. Shen-Orr,et al. Network motifs in the transcriptional regulation network of Escherichia coli , 2002, Nature Genetics.
[111] A. Hoffmann,et al. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.
[112] G. Barber. Host defense, viruses and apoptosis , 2001, Cell Death and Differentiation.
[113] G. Petsko. The dark side , 2000, Genome Biology.
[114] P. Branton,et al. Viruses and apoptosis. , 1999, Annual review of microbiology.
[115] K. Keyomarsi,et al. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. , 1991, Cancer research.
[116] A. Morley,et al. Delayed DNA methylation is an integral feature of DNA replication in mammalian cells. , 1986, Experimental cell research.
[117] W. Stewart,et al. Interferon priming. Effects on interferon messenger RNA. , 1979, The Journal of biological chemistry.
[118] K. Smith. What is a Virus? , 1955, Nature.